Volume 24, Issue 3
Noninvasive Therapies: A Forthcoming Approach to Parkinson's Treatment
Pp: 165-180
Author(s): Umer Anayyat, Faiza Ahad, Bushra Muhammad Fordil, Hajra Hameed, Mengqing Li, Qinyao Yu, Yunpeng Wei and Xiaomei Wang*
DOI: 10.2174/0118715273318429240812094557
A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson’s Disease: An Updated Patent and Clinical Trials
Pp: 181-195
Author(s): Sara Khan and Md. Faheem Haider*
DOI: 10.2174/0118715273323074241001071645
Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease
Pp: 196-207
Author(s): Parneet Kaur, Heena Khan, Amarjot Kaur Grewal, Kamal Dua, Sachin Kumar Singh, Gaurav Gupta and Thakur Gurjeet Singh*
DOI: 10.2174/0118715273321002240919102841
Hypoxia-inducible Factor-1α Pathway in Cerebral Ischemia: From Molecular Mechanisms to Therapeutic Targets
Pp: 208-218
Author(s): Veerta Sharma and Thakur Gurjeet Singh*
DOI: 10.2174/0118715273324551241008111827
Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects
Pp: 219-233
Author(s): Farha Bano, Faris F. Aba Alkhayl, Mohammad Rashid, Mohammed Ghanim Alqethami, Mohammed Omair Alsufyani, Khadijah Oudah R Alhothali, Mohammed Japer Mohammed Hakme, Abdulrahman Mohammed Al-Jarallah, Rikeshwer Prasad Dewangan* and Asif Husain*
DOI: 10.2174/0118715273306929240820071521
The Alpha-7 Nicotinic Receptor Positive Allosteric Modulator PNU120596 Attenuates Lipopolysaccharide-Induced Depressive-Like Behaviors and Cognitive Impairment by Regulating the PPAR-α Signaling Pathway in Mice
Pp: 234-244
Author(s): Sami Alzarea and Shafiqur Rahman*
DOI: 10.2174/0118715273311527240916050749
